‌

US Patent 11969419 Method of treating cancer

Patent 11969419 was granted and assigned to Exelixis, Inc on April, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Maha Hussain0

David Smith0

Date of Patent

April 30, 2024

0

Patent Application Number

181122140

Date Filed

February 21, 2023

0

Patent Citations

US Patent 8178532 c-Met modulators and method of use

0

US Patent 8314232 Preparation of a quinolinyloxydiphenylcyclopropanedicarboxamide

0

US Patent 8476298 c-Met modulators and method of use

0

US Patent 8497284 C-met modulators and method of use

0

US Patent 8673912 Crystalline Forms on N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]-quinolin-4-yl}oxy)phenyl]-N′-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide

0

US Patent 8877776 (L)-malate salt of N-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide

0

US Patent 9174947 c-Met modulators and methods of use

0

US Patent 9717720 Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds

0

...

Patent Primary Examiner

Timothy R Rozof

0

CPC Code

0

0

0

0

0

Patent abstract

This invention is directed to the treatment of cancer, particularly castration-resistant prostate cancer and osteoblastic bone metastases, with a dual inhibitor of MET and VEGF.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11969419 Method of treating cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.